• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.29% Nasdaq Up 0.52%

    Biogen Inc. (BIIB)

    -NasdaqGS
    287.78 Up 5.33(1.89%) Jul 22, 4:00PM EDT
    |After Hours : 288.37 Up 0.59 (0.21%) Jul 22, 7:41PM EDT
    Prev Close:282.45
    Open:282.09
    Bid:288.37 x 100
    Ask:297.00 x 100
    1y Target Est:332.50
    Beta:0.282631
    Earnings Date:Oct 19 - Oct 24 (Est.)
    Day's Range:281.38 - 290.92
    52wk Range:223.02 - 338.51
    Volume:3,394,578
    Avg Vol (3m):1,870,940
    Market Cap:63.04B
    P/E (ttm):17.69
    EPS (ttm):16.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 1.89%63.04B
    PFEUp 0.08%222.82B
    ABTUp 0.30%63.42B

    Key Statistics

    Forward P/E (1 yr):13.83
    P/S (ttm):5.66
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :19.81
    Quarterly EPS Est (Sep-16) :5.02
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.61

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback